BioNTech | Results Presentation Deck | 32 slides

BioNTech · 2022-08
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

32
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
This is a standard pharmaceutical regulatory disclosure slide.other
04
Standard pharmaceutical regulatory disclosure slide.other
06
front_matter
07
Uses a three-column horizontal progression layout representing time horizons.plan_implementation
08
summarize
09
The slide uses a three-row layout to categorize updates into label expansion, distribution, and R&D progress.summarize
10
The chart shows the rapid succession of Omicron sub-lineages in the USA between Dec 2021 and June 2022.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
11
The slide uses a process-oriented layout to show how three workstreams converge into a single launch event.plan_implementation
Open slide detailLoop · Cost Of Inaction
12
front_matter
Open slide detailLoop · Cost Of Inaction
13
Data shows monovalent BA.1 and bivalent vaccines as 4th doses; includes LOD line and statistical superiority/non-inferiority notes.analyze_data
Open slide detailLoop · Cost Of Inaction
14
The slide uses a 3D protein structure visualization and a heatmap to show mutation differences between Omicron lineages.analyze_data
Open slide detailBeat · AgitateLoop · Cost Of Inaction
15
The chart uses a logarithmic scale for the y-axis (pVN50 titer).analyze_data
Open slide detailBeat · AgitateLoop · Cost Of Inaction
16
The slide outlines three distinct R&D pillars for COVID-19 vaccines.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
17
The slide uses a Gantt-style visualization to represent clinical trial phases for various drug candidates.present_framework
18
The slide uses a process flow diagram to illustrate patient stratification into different treatment cohorts.present_framework
19
Includes a citation to a Nature Medicine paper and a pipeline table.present_solution
20
Includes bar chart of neoantigen counts, line chart of immune response over time, and Kaplan-Meier survival curve.analyze_data
21
The slide highlights the mechanism of action for bispecific antibodies and a monospecific HexaBody, emphasizing their role in T cell and NK cell activation.present_solution
22
front_matter
23
summarize
24
analyze_data
25
Includes earnings per share data and footnotes regarding rounding and collaboration profit sharing.analyze_data
26
summarize
27
front_matter
28
Includes footnotes detailing market definitions and data sources.summarize
29
summarize
30
The slide uses a grouped table structure to categorize milestones by therapeutic area.plan_implementation
31
summarize
32
summarize